Board Of Directors

Dr. Vladimir Cmiljanovic, Chief Executive Officer and Founder, is one of Switzerland's leading serial pharma entrepreneurs, a medicinal chemist, and a cancer scientist with more than fifteen years of experience in oncology drug development. He is co-author of numerous scientific articles and abstracts and inventor of several patent families with more than 400 registered patents.

Dr. Natasa Cmiljanovic, Chief Scientific Officer and Founder, is a medicinal chemist and clinical scientist with more than ten years of experience in oncology drug development. She is the co-author of various scientific articles and abstracts and inventor of numerous patents.

André Debrunner, Vice-Chairman, is Chief Operating Officer of Northern Trust Switzerland with responsibility for fund accounting, fund reporting, custody services and IT. He is a member of the Northern Trust Switzerland Management Committee.

Dr. Thomas Ladner, Board Member and Secretary of the Board, became in 2002 the youngest partner at Meyerlustenberger Lachenal, one of Switzerland's leading law firms, where he specialized in private equity and M&A. From 2000 to 2004, Thomas lectured on corporate law and contract law at the University of St. Gallen (Switzerland), from where he also holds a Ph.D.

Prof. Dr. Michael N. Hall, Board Member, is an American and Swiss molecular biologist and Professor at the Biozentrum of the University of Basel. He earned a PhD in Molecular Genetics from Harvard University in 1981 and was a postdoctoral fellow at the Institut Pasteur in Paris and the University of California, San Francisco.